Ciclosporin in the Management of New Erythema Nodosum Leprosum
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Study 2A: Ciclosporin in the management of new Erythema Nodosum Leprosum
Objective: A pilot (double blind controlled) study randomizing patients to treatment either
with Ciclosporin or Prednisolone to assess the safety, tolerability and efficacy of
Ciclosporin in the treatment of patients with new acute Type 2 reactions (ENL).
Phase:
Phase 2
Details
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborators:
Alert Hospital, Ethiopia Armauer Hansen Research Institute, Ethiopia Homes and Hospitals of St Giles